Cholangiocarcinoma occurring in a patient with type 1 Gaucher disease treated with velaglucerase alfa enzyme replacement therapy: First case report

Blood Cells Mol Dis. 2018 Feb:68:112-114. doi: 10.1016/j.bcmd.2017.05.010. Epub 2017 May 24.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Bile Duct Neoplasms / etiology*
  • Cholangiocarcinoma / etiology*
  • Enzyme Replacement Therapy / adverse effects
  • Female
  • Gaucher Disease / complications*
  • Gaucher Disease / drug therapy*
  • Glucosylceramidase / adverse effects*
  • Glucosylceramidase / therapeutic use
  • Humans
  • Recombinant Proteins / adverse effects
  • Recombinant Proteins / therapeutic use

Substances

  • Recombinant Proteins
  • Glucosylceramidase
  • Velaglucerase alfa, human